Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

NEW LGC AccuSet HBsAg Performance Panel

Products are for professional/laboratory use only.

Abacus dx is happy to announce the launch of NEW AccuSet HBsAg Performance Panel from LGC.

The AccuSet™ HBsAg Performance Panel is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples and comprehensive data are provided for comparative analysis. For research use only. Not for use in diagnostic procedures.

This product is a 25-member HBsAg performance panel. Panel members represent bleeds from multiple individuals positive for HBsAg and other HBV analytes. Panel members consist of undiluted, naturally-occurring plasma samples. Each sample represents a single collection event. One sample is included as a non-reactive sample and is negative for all HBV methods tested. No preservatives were added.

For more information about this pannel please view the below Datasheet & Package Insert for your reference.

View the Package Insert >

Download Now >

View the Datasheet >

Download Now >

View the SeraCare Product Catalogue >

Download Now >

Request a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article